|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 211/58 | |
| A61K 31/4468 | |||
| A61P 25/00 | |||
| A61P 7/02 |
| (11) | Patento numeris | 2289879 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10180395.5 |
| Europos patento paraiškos padavimo data | 2005-09-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-11-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 614014 P | 2004-09-27 | US |
| (72) |
Thygesen, Mikkel, DK
Schlienger, Nathalie, CH
Tolf, Bo-Ragnar, SE
Andersson, Carl-Magnus, SE
Blatter, Fritz, CH
Berghausen, Jörg, DE
|
| (73) |
Acadia Pharmaceuticals Inc.,
11085 Torreyana Road, Ste. 100, San-Diego, CA 92121-1104,
US
|
| (54) | Synthesis of a crystalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n`-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt |
| Synthesis of a crystalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n`-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt |